1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Tissue Diagnostics Market by Technology, Disease, Product, and End Users & Region - Global Forecast to 2020

The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020.

The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments.

Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development: Product portfolios of the top players in the tissue diagnostics market.
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various tissue diagnostics products across geographies.

Table Of Contents

Tissue Diagnostics Market by Technology, Disease, Product, and End Users and Region - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3 MARKET SHARE ESTIMATION 23
2.3.1 KEY DATA FROM SECONDARY SOURCES 24
2.3.2 KEY DATA FROM PRIMARY SOURCES 24
2.3.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 31
4.1 GLOBAL TISSUES DIAGNOSTICS MARKET OVERVIEW 31
4.2 LIFE CYCLE ANALYSIS, BY REGION 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.1.1 BY DISEASE 36
5.1.2 BY END USER 37
5.1.3 BY PRODUCT 37
5.1.4 BY TECHNOLOGY 37
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Rising incidences of cancer 39
5.2.1.2 Rapidly increasing aging population 39
5.2.1.3 Growing healthcare expenditure 39
5.2.2 RESTRAINTS 41
5.2.2.1 Stringent regulatory requirements and compliance 41
5.2.2.2 High degree of consolidation 41
5.2.2.3 Budget constraints 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 High growth in emerging markets 42
5.2.3.2 Increased use of personalized medicine 43
5.2.4 TREND 43
5.2.4.1 Increasing number of reagent rental agreements 43
6 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 45
6.1 INTRODUCTION 46
6.2 CONSUMABLES 47
6.2.1 ANTIBODIES 50
6.2.2 KITS 51
6.2.3 REAGENTS 52
6.2.4 PROBES 53
6.3 INSTRUMENTS 54
6.3.1 SLIDE-STAINING SYSTEMS 57
6.3.2 SCANNERS 58
6.3.3 TISSUE-PROCESSING SYSTEMS 59
6.3.4 OTHER INSTRUMENTS 60
7 TISSUE DIAGNOSTICS MARKET, BY DISEASES 61
7.1 INTRODUCTION 62
7.2 BREAST CANCER 64
7.3 GASTRIC CANCER 66
7.4 LYMPHOMA 67
7.5 PROSTATE CANCER 69
7.6 NON-SMALL CELL LUNG CANCER 70
7.7 OTHER DISEASES 72
8 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 74
8.1 INTRODUCTION 75
8.2 IMMUNOHISTOCHEMISTRY (IHC) 76
8.3 IN SITU HYBRIDIZATION (ISH) 78
8.4 DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT 79
8.5 SPECIAL STAINING 81
9 TISSUE DIAGNOSTICS MARKET, BY END USER 83
9.1 INTRODUCTION 84
9.2 HOSPITALS 85
9.3 RESEARCH LABORATORIES 87
9.4 PHARMACEUTICAL COMPANIES 88
9.5 CONTRACT RESEARCH ORGANIZATIONS 89
9.6 OTHER END USERS 91
10 TISSUE DIAGNOSTICS MARKET, BY REGION 92
10.1 INTRODUCTION 93
10.2 NORTH AMERICA 95
10.2.1 U.S. 102
10.2.2 CANADA 104
10.3 EUROPE 107
10.4 ASIA 113
10.5 REST OF THE WORLD (ROW) 120
11 COMPETITIVE LANDSCAPE 127
11.1 INTRODUCTION 127
11.2 STRATEGIC OVERVIEW 127
11.3 LEADING PLAYERS IN THE TISSUE DIAGNOSTICS MARKET 128
11.4 COMPETITIVE SITUATION AND TRENDS 130
11.4.1 NEW PRODUCTS LAUNCHES AND PRODUCT UPGRADES 131
11.4.2 ACQUISITIONS 132
11.4.3 EXPANSIONS 133
11.4.4 AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS 133
11.4.5 OTHER DEVELOPMENTS 134
12 COMPANY PROFILES 135
12.1 INTRODUCTION 135
12.2 ABBOTT LABORATORIES, INC. 136
12.3 AGILENT TECHNOLOGIES, INC. 139
12.4 BIO SB 142
12.5 BIOGENEX LABORATORIES 144
12.6 CELL SIGNALING TECHNOLOGY, INC. 146
12.7 DANAHER CORPORATION 148
12.8 F. HOFFMAN-LA ROCHE AG 151
12.9 SAKURA FINETEK JAPAN CO., LTD. 154
12.10 SIGMA-ALDRICH CORPORATION 156
12.11 THERMO FISHER SCIENTIFIC 159
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13 APPENDIX 162
13.1 INSIGHTS OF INDUSTRY EXPERTS 162
13.2 DISCUSSION GUIDE 163
13.3 OTHER DEVELOPMENTS 165
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 173
13.5 AVAILABLE CUSTOMIZATIONS 174
13.6 RELATED REPORTS 175


LIST OF TABLES

TABLE 1 TISSUE DIAGNOSTICS MARKET SUMMARY 26
TABLE 2 RISING INCIDENCES OF CANCER ARE THE PRIMARY DRIVER FOR THE TISSUE DIAGNOSTICS MARKET 40
TABLE 3 STRINGENT REGULATORY REQUIREMENTS IS A KEY RESTRAINT FOR THE GROWTH OF THE TISSUE DIAGNOSTICS MARKET 42
TABLE 4 EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES 43
TABLE 5 INCREASING NUMBER OF REAGENT RENTAL AGREEMENTS IS A MAJOR TREND FOR THE GROWTH OF THIS MARKET 44
TABLE 6 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 47
TABLE 7 TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES,
2013-2020 (USD MILLION) 48
TABLE 8 TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION,
2013-2020 (USD MILLION) 49
TABLE 9 TISSUE DIAGNOSTICS MARKET SIZE FOR ANTIBODIES, BY REGION,
2013-2020 (USD MILLION) 51
TABLE 10 TISSUE DIAGNOSTICS MARKET SIZE FOR KITS, BY REGION,
2013-2020 (USD MILLION) 52
TABLE 11 TISSUE DIAGNOSTICS MARKET SIZE FOR REAGENTS, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 12 TISSUE DIAGNOSTICS MARKET SIZE FOR PROBES, BY REGION,
2013-2020 (USD MILLION) 54
TABLE 13 TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2013-2020 (USD MILLION) 55
TABLE 14 TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION,
2013-2020 (USD MILLION) 56
TABLE 15 TISSUE DIAGNOSTICS MARKET SIZE FOR SLIDE-STAINING SYSTEMS, BY REGION, 2013-2020 (USD MILLION) 57
TABLE 16 TISSUE DIAGNOSTICS MARKET SIZE FOR SCANNERS, BY REGION,
2013-2020 (USD MILLION) 58
TABLE 17 TISSUE DIAGNOSTICS MARKET SIZE FOR TISSUE-PROCESSING SYSTEMS,
BY REGION, 2013-2020 (USD MILLION) 59
TABLE 18 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 19 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION) 63
TABLE 20 TISSUE DIAGNOSTICS MARKET SIZE FOR BREAST CANCER, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 21 TISSUE DIAGNOSTICS MARKET SIZE FOR GASTRIC CANCER, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 22 TISSUE DIAGNOSTICS MARKET SIZE FOR LYMPHOMA, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 23 TISSUE DIAGNOSTICS MARKET SIZE FOR PROSTATE CANCER, BY REGION,
2013-2020 (USD MILLION) 70
TABLE 24 TISSUE DIAGNOSTICS MARKET SIZE FOR NON-SMALL CELL LUNG CANCER,
BY REGION, 2013-2020 (USD MILLION) 71
TABLE 25 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER DISEASES, BY REGION,
2013-2020 (USD MILLION) 73
TABLE 26 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 75
TABLE 27 TISSUE DIAGNOSTICS MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2013-2020 (USD MILLION) 77
TABLE 28 TISSUE DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY REGION, 2013-2020 (USD MILLION) 79
TABLE 29 TISSUE DIAGNOSTICS MARKET SIZE FOR DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT, BY REGION, 2013-2020 (USD MILLION) 80
TABLE 30 TISSUE DIAGNOSTICS MARKET SIZE FOR SPECIAL STAINING, BY REGION,
2013-2020 (USD MILLION) 82
TABLE 31 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 85
TABLE 32 TISSUE DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION,
2013-2020 (USD MILLION) 86
TABLE 33 TISSUE DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES, BY REGION, 2013-2020 (USD MILLION) 88
TABLE 34 TISSUE DIAGNOSTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES,
BY REGION, 2013-2020 (USD MILLION) 89
TABLE 35 TISSUE DIAGNOSTICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION) 90
TABLE 36 TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION,
2013-2020 (USD MILLION) 91
TABLE 37 TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 94
TABLE 38 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 96
TABLE 39 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 97
TABLE 40 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES,
BY TYPE, 2013-2020 (USD MILLION) 98
TABLE 41 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS,
BY TYPE, 2013-2020 (USD MILLION) 99
TABLE 42 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 100
TABLE 43 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 101
TABLE 44 NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 102
TABLE 45 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 103
TABLE 46 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 103
TABLE 47 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 104
TABLE 48 U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 104
TABLE 49 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 105
TABLE 50 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 106
TABLE 51 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 106
TABLE 52 CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 107
TABLE 53 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 108
TABLE 54 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION) 109
TABLE 55 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 56 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 111
TABLE 57 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 112
TABLE 58 EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 113
TABLE 59 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 115
TABLE 60 ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 116
TABLE 61 ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2013-2020 (USD MILLION) 117
TABLE 62 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 118
TABLE 63 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 119
TABLE 64 ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 120
TABLE 65 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 121
TABLE 66 ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2013-2020 (USD MILLION) 122
TABLE 67 ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2013-2020 (USD MILLION) 123
TABLE 68 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE,
2013-2020 (USD MILLION) 124
TABLE 69 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 125
TABLE 70 ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 126
TABLE 71 MARKET DEVELOPMENTS BETWEEN 2012 AND 2015 130
TABLE 72 NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES, 2012-2015 131
TABLE 73 ACQUISITIONS, 2012-2015 132
TABLE 74 EXPANSIONS, 2012-2015 133
TABLE 75 AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS, 2012-2015 133
TABLE 76 OTHER DEVELOPMENTS, 2012-2015 134


LIST OF FIGURES

FIGURE 1 GLOBAL TISSUE DIAGNOSTICS MARKET 17
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 27
FIGURE 8 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY,
2015 VS. 2020 (USD MILLION) 27
FIGURE 9 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 VS. 2020 (USD MILLION) 28
FIGURE 10 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 29
FIGURE 11 TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 30
FIGURE 12 RISING INCIDENCES OF CANCER TO DRIVE MARKET GROWTH 31
FIGURE 13 IMMUNOHISTOCHEMISTRY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 32
FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
(2015 TO 2020) 33
FIGURE 15 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES 34
FIGURE 16 TISSUE DIAGNOSTICS MARKET, BY DISEASE 36
FIGURE 17 TISSUE DIAGNOSTICS MARKET, BY END USER 37
FIGURE 18 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 37
FIGURE 19 TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY 37
FIGURE 20 INCREASING INCIDENCES OF CANCER ARE EXPECTED TO DRIVE THE TISSUE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 38
FIGURE 21 INCREASING HEALTHCARE EXPENDITURE WILL DRIVE THE TISSUE DIAGNOSTICS MARKET 40
FIGURE 22 RAPID GROWTH IN HEALTHCARE EXPENDITURE IN EMERGING MARKETS IS AN IMPORTANT GROWTH OPPORTUNITY 42
FIGURE 23 TISSUE DIAGNOSTICS MARKET, BY PRODUCT 46
FIGURE 24 TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 (USD MILLION) 46
FIGURE 25 TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2015 (USD MILLION) 48
FIGURE 26 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CONSUMABLES PRODUCT SEGMENT IN 2015 49
FIGURE 27 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ANTIBODIES PRODUCT SEGMENT IN 2015 50
FIGURE 28 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE KITS PRODUCT SEGMENT IN 2015 51
FIGURE 29 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE REAGENTS PRODUCT SEGMENT IN 2015 52
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROBES PRODUCT SEGMENT IN 2015 53
FIGURE 31 TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2015 (USD MILLION) 55
FIGURE 32 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE INSTRUMENTS PRODUCT SEGMENT IN 2015 56
FIGURE 33 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SLIDE-STAINING SYSTEMS PRODUCT SEGMENT IN 2015 57
FIGURE 34 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SCANNERS PRODUCT SEGMENT IN 2015 58
FIGURE 35 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE TISSUE-PROCESSING SYSTEMS PRODUCT SEGMENT IN 2015 59
FIGURE 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER INSTRUMENTS PRODUCT SEGMENT IN 2015 60
FIGURE 37 TISSUE DIAGNOSTICS MARKET, BY DISEASE 62
FIGURE 38 TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 (USD MILLION) 63
FIGURE 39 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE BREAST CANCER DISEASE SEGMENT IN 2015 65
FIGURE 40 ASIA TO BE THE FASTEST-GROWING SEGMENT IN THE TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER DURING THE FORECAST PERIOD 66
FIGURE 41 ASIA TO WITNESS HIGHEST GROWTH IN THE LYMPHOMA DISEASE SEGMENT DURING THE FORECAST PERIOD 68
FIGURE 42 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROSTATE CANCER DISEASE SEGMENT IN 2015 69
FIGURE 43 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE NON-SMALL CELL LUNG CANCER DISEASE SEGMENT IN 2015 71
FIGURE 44 ASIA TO BE THE FASTEST-GROWING MARKET IN THE OTHER DISEASES SEGMENT DURING THE FORECAST PERIOD 72
FIGURE 45 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY 75
FIGURE 46 TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2015 (USD MILLION) 75
FIGURE 47 NORTH AMERICA TO DOMINATE THE IMMUNOHISTOCHEMISTRY TECHNOLOGY SEGMENT IN 2015 77
FIGURE 48 ASIA TO BE THE FASTEST-GROWING MARKET IN THE IN SITU HYBRIDIZATION TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD 78
FIGURE 49 ASIA TO WITNESS HIGHEST GROWTH IN THE DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD 80
FIGURE 50 NORTH AMERICA TO DOMINATE THE SPECIAL STAINING TECHNOLOGY
SEGMENT IN 2015 81
FIGURE 51 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY END USER 84
FIGURE 52 TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 (USD MILLION) 84
FIGURE 53 NORTH AMERICA TO DOMINATE THE HOSPITAL END-USER SEGMENT IN 2015 86
FIGURE 54 THE RESEARCH LABORATORIES END-USER SEGMENT IN ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 87
FIGURE 55 PHARMACEUTICAL COMPANIES SEGMENT IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 88
FIGURE 56 NORTH AMERICA TO DOMINATE THE CONTRACT RESEARCH ORGANIZATIONS END-USER SEGMENT IN 2015 90
FIGURE 57 NORTH AMERICA TO DOMINATE THE OTHER END-USERS SEGMENT IN 2015 91
FIGURE 58 TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY REGION 93
FIGURE 59 NORTH AMERICA TO DOMINATE THE GLOBAL TISSUE DIAGNOSTICS MARKET
IN 2015 93
FIGURE 60 TISSUE DIAGNOSTICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 94
FIGURE 61 NORTH AMERICA: MARKET SNAPSHOT 95
FIGURE 62 U.S. IS EXPECTED TO BE THE FASTEST-GROWING MARKET IN NORTH AMERICA
IN 2015 96
FIGURE 63 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD 97
FIGURE 64 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD 98
FIGURE 65 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD 99
FIGURE 66 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN NORTH AMERICA IN 2015 100
FIGURE 67 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN NORTH AMERICA IN 2015 101
FIGURE 68 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA
IN 2015 101
FIGURE 69 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN EUROPE DURING THE FORECAST PERIOD 108
FIGURE 70 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN EUROPE DURING THE FORECAST PERIOD 109
FIGURE 71 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN EUROPE DURING THE FORECAST PERIOD 110
FIGURE 72 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN EUROPE IN 2015 111
FIGURE 73 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2015 112
FIGURE 74 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015 112
FIGURE 75 ASIA: MARKET SNAPSHOT 114
FIGURE 76 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ASIA DURING THE FORECAST PERIOD 115
FIGURE 77 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ASIA DURING THE FORECAST PERIOD 116
FIGURE 78 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ASIA DURING THE FORECAST PERIOD 117
FIGURE 79 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ASIA IN 2015 118
FIGURE 80 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ASIA IN 2015 119
FIGURE 81 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015 119
FIGURE 82 CONSUMABLES COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ROW DURING THE FORECAST PERIOD 121
FIGURE 83 ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ROW DURING THE FORECAST PERIOD BETWEEN 2015-2020 122
FIGURE 84 SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ROW DURING THE FORECAST PERIOD 123
FIGURE 85 BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ROW IN 2015 124
FIGURE 86 IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ROW IN 2015 125
FIGURE 87 HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015 125
FIGURE 88 KEY DEVELOPMENTS IN THE TISSUE DIAGNOSTICS MARKET, 2010-2015 127
FIGURE 89 TISSUE DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 128
FIGURE 90 SNAPSHOT OF THE FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 135
FIGURE 91 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT 136
FIGURE 92 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 139
FIGURE 93 DANAHER CORPORATION: COMPANY SNAPSHOT 148
FIGURE 94 F. HOFFMAN-LA ROCHE AG: COMPANY SNAPSHOT 151
FIGURE 95 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 156
FIGURE 96 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 159

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.